Welcome to InhibOxInhibOx develops novel and effective computational methods for drug discovery, to improve the productivity of lead and candidate identification. InhibOx was founded in 2001 by Professor W. Graham Richards, former Chairman of Chemistry at the University of Oxford and world leading computational chemist. The company grew from the outstandingly successful Screensaver Lifesaver project which involved some 3.5 million personal computers in over 200 countries: the world's biggest computational chemistry experiment finding lead compounds to inhibit cancer targets, anthrax and smallpox. Since then, InhibOx has built up a significant technology platform in virtual screening. Our ongoing research activities comprise the development of entirely novel computational drug discovery methods and the development of Scopius and CSpace, a very large and carefully curated database of commercially-available chemical structures.
DrugFinder is our virtual screening web service that searches millions of commercially-available molecules against a target protein structure you supply—and it's free to academics. more... |
|
Apply to the InhibOx/NFCR
virtual screening service
The website of our FP6 consortium.
InhibOx works closely with
MolPort, a one-stop shop for
compound acquisition.
